SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol



McCarthy, Caroline, Sacco, Joseph, Fedele, Stefano, Ho, Michael, Porter, Stephen, Liloglou, Triantafillos ORCID: 0000-0003-0460-1404, Greenhalf, Bill, Robinson, Max, Young, Bridget ORCID: 0000-0001-6041-9901, Cicconi, Silvia
et al (show 5 more authors) (2021) SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol. TRIALS, 22 (1).

This is the latest version of this item.

[img] Text
SAVER trial protocol paper.pdf - OA Published Version

Download (1MB) | Preview
Item Type: Article
Uncontrolled Keywords: Oral epithelial dysplasia, Sodium valproate, Epigenetic reprogramming, Drug repurposing, Randomised controlled trial, Chemoprevention
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Population Health
Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology
Depositing User: Symplectic Admin
Date Deposited: 15 Jul 2021 09:10
Last Modified: 23 Oct 2021 07:11
DOI: 10.1186/s13063-021-05373-8
Open Access URL: https://trialsjournal.biomedcentral.com/articles/1...
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3130119

Available Versions of this Item